ITGAM and neoplasm: Increased staining for CD11b and FOXP3 was detected in poor responder patients compared to good responders (Figure 6A–6B; see Supplementary Figure 2) [21, 26], specifically in island of tumor budding, a rectal cancer poor prognostic factor [27] (Figure 6B).